Michael A. Carrier

Rutgers Law School

Distinguished Professor

217 North Fifth Street

Camden, NJ 08102-1203

United States

SCHOLARLY PAPERS

105

DOWNLOADS
Rank 546

SSRN RANKINGS

Top 546

in Total Papers Downloads

34,016

CITATIONS
Rank 9,426

SSRN RANKINGS

Top 9,426

in Total Papers Citations

46

Scholarly Papers (105)

1.

Copyright and Innovation: The Untold Story

2012 Wisconsin Law Review 891
Number of pages: 72 Posted: 04 Jul 2012 Last Revised: 04 Dec 2012
Michael A. Carrier
Rutgers Law School
Downloads 7,333 (659)

Abstract:

Loading...

copyright, innovation, music, peer-to-peer (p2p), venture capital, napster, Innovator's Dilemma, record labels, SOPA, PIPA, statutory damages, personal liability

2.

A Roadmap to the Smartphone Patent Wars and FRAND Licensing

CPI Antitrust Chronicle, Vol. 2, April 2012
Number of pages: 7 Posted: 04 May 2012
Michael A. Carrier
Rutgers Law School
Downloads 3,016 (3,211)

Abstract:

Loading...

Smartphones, patents, patent wars, standards, RAND, FRAND, antitrust

3.

Cabining Intellectual Property Through a Property Paradigm

Duke Law Journal, Vol. 54, No. 1, October 2004
Number of pages: 145 Posted: 30 Apr 2004
Michael A. Carrier
Rutgers Law School
Downloads 1,617 (9,167)
Citation 11

Abstract:

Loading...

Intellectual property, property, propertization, patent, copyright, trademark, right of publicity

4.

Against Cyberproperty

Berkeley Technology Law Journal, Vol. 22, 2007
Number of pages: 36 Posted: 25 Apr 2007 Last Revised: 06 Apr 2008
Michael A. Carrier and Greg Lastowka
Rutgers Law School and Rutgers School of Law
Downloads 1,073 (17,501)
Citation 2

Abstract:

Loading...

cyberproperty, property, cyberspace, Locke, Hegel, utilitarianism, spam, electronic invasion, copyright

5.

The Untold EpiPen Story: How Mylan Hiked Prices by Blocking Rivals

102 Cornell Law Review Online 53 (2017)
Number of pages: 20 Posted: 21 Sep 2016 Last Revised: 01 Feb 2017
Michael A. Carrier and Carl Minniti
Rutgers Law School and Independent
Downloads 972 (20,321)

Abstract:

Loading...

EpiPen, Mylan, antitrust, settlement, citizen petition, exclusive dealing, Teva

6.

Innovation for the 21st Century: Harnessing the Power of Intellectual Property and Antitrust Law

Oxford University Press, 2009
Number of pages: 16 Posted: 27 Mar 2009
Michael A. Carrier
Rutgers Law School
Downloads 763 (28,746)
Citation 3

Abstract:

Loading...

innovation, patent, copyright, antitrust, IP-antitrust intersection, P2P, statutory damages, DMCA, post-grant opposition, eBay, biotechnology research tools, material transfer agreements (MTAs), innovation markets, standard-setting organizations (SSOs), Hatch-Waxman Act, pharmaceutical settlements

7.

The Pirate Bay, Grokster, and Google

Journal of Intellectual Property Rights, Vol. 15, pp. 7-18, January 2010
Number of pages: 12 Posted: 04 Oct 2009 Last Revised: 27 Oct 2012
Michael A. Carrier
Rutgers Law School
Downloads 647 (36,035)

Abstract:

Loading...

The Pirate Bay, Google, Grokster, copyright, file-sharing, P2P, BitTorrent, secondary liability, piracy, infringement

8.

Using Antitrust Law to Challenge Turing's Daraprim Price Increase

31 Berkeley Technology Law Journal 1379 (2017)
Number of pages: 30 Posted: 29 Jan 2016 Last Revised: 14 Jul 2017
Michael A. Carrier, Nicole Levidow and Aaron S. Kesselheim
Rutgers Law School, Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics and Brigham and Women's Hospital/Harvard Medical School
Downloads 640 (36,522)

Abstract:

Loading...

Turing, Shkreli, antitrust, monopolization, drugs, pharmaceuticals, Daraprim, pyrimethamine

9.

Two Puzzles Resolved: Of the Schumpeter - Arrow Stalemate and Pharmaceutical Innovation Markets

Iowa Law Review, Vol. 93, 2008
Number of pages: 58 Posted: 09 Apr 2007 Last Revised: 02 Jun 2013
Michael A. Carrier
Rutgers Law School
Downloads 640 (36,590)
Citation 2

Abstract:

Loading...

antitrust, innovation market, schumpeter, arrow, market structure, innovation, mergers, patents, pharmaceuticals

10.

Patent Assertion Entities: Six Actions the Antitrust Agencies Can Take

CPI Antitrust Chronicle, Winter 2013, Vol. 1 No. 2
Number of pages: 12 Posted: 31 Jan 2013
Michael A. Carrier
Rutgers Law School
Downloads 624 (37,749)

Abstract:

Loading...

patent assertion entity (PAE), nonpracticing entity (NPE), patent troll, antitrust

11.

A Real-World Analysis of Pharmaceutical Settlements: The Missing Dimension of Product-Hopping

Florida Law Review, Vol. 62, 2010
Number of pages: 28 Posted: 14 Apr 2010 Last Revised: 28 Dec 2013
Michael A. Carrier
Rutgers Law School
Downloads 623 (37,823)

Abstract:

Loading...

patent, antitrust, settlement, product hopping, drugs, pharmaceuticals, Hatch Waxman, reverse payments

12.

No, RIAA, It's Not the End of the World for Musicians

University of Missouri-Kansas City Law Review, 2014
Number of pages: 16 Posted: 05 May 2015
Michael A. Carrier
Rutgers Law School
Downloads 575 (42,139)

Abstract:

Loading...

music, musicians, copyright, GarageBand, Twitter, YouTube, Topspin, Bandcamp, CD Baby Pro, TuneCore, Kickstarter, Indiegogo, Songkick, Bandsintown

13.

Resolving the Patent-Antitrust Paradox Through Tripartite Innovation

Number of pages: 65 Posted: 19 Feb 2003
Michael A. Carrier
Rutgers Law School
Downloads 557 (43,799)
Citation 4

Abstract:

Loading...

Innovation, patent, antitrust, industry, monopoly

14.

RAND Patents and Exclusion Orders: Submission of 19 Economics and Law Professors to the International Trade Commission

Santa Clara Univ. Legal Studies Research Paper No. 07-12, UC Berkeley Public Law Research Paper No. 2102865
Number of pages: 13 Posted: 10 Jul 2012
Santa Clara University - School of Law, University of California, Berkeley - Department of Economics, University of California, Berkeley - Haas School of Business, University of Minnesota Law School, Notre Dame Law School, Syracuse University College of Law, Santa Clara University - School of Law, University of California, Irvine School of Law, Pennsylvania State University - Mary Jean and Frank P. Smeal College of Business Administration, Rutgers Law School, University of Utah - S.J. Quinney College of Law, University of Georgia School of Law, Villanova University Charles Widger School of Law, New York University School of Law, University of San Diego School of Law, Duke University School of Law, New York University School of Law, University of Leuven and University of Nebraska - College of Law
Downloads 553 (44,237)
Citation 1

Abstract:

Loading...

15.

Unsettling Drug Patent Settlements: A Framework for Presumptive Illegality

Michigan Law Review, Vol. 108
Number of pages: 44 Posted: 11 Mar 2009 Last Revised: 05 May 2015
Michael A. Carrier
Rutgers Law School
Downloads 515 (48,343)
Citation 4

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, Hatch Waxman, reverse payments

16.

What You Need to Know About Standard Essential Patents

Competition Policy International (Vol. 8, No. 2, 2014)
Number of pages: 10 Posted: 27 Aug 2014 Last Revised: 10 Dec 2014
Michael A. Carrier
Rutgers Law School
Downloads 511 (48,834)

Abstract:

Loading...

Standard essential patents, SEPs, RAND, FRAND, antitrust, injunctions

17.

Product Hopping: A New Framework

92 Notre Dame Law Review, 167 (2016)
Number of pages: 65 Posted: 16 Mar 2016 Last Revised: 25 Feb 2017
Michael A. Carrier and Steve Shadowen
Rutgers Law School and Hilliard & Shadowen LLP
Downloads 428 (61,296)

Abstract:

Loading...

product hopping, pharmaceuticals, drugs, antitrust, no economic sense, reformulations, Hatch Waxman, state DPS laws

18.

A Tort-Based Causation Framework for Antitrust Analysis

Antitrust Law Journal, Forthcoming
Number of pages: 26 Posted: 15 Oct 2011 Last Revised: 17 Oct 2011
Michael A. Carrier
Rutgers Law School
Downloads 420 (62,339)

Abstract:

Loading...

causation, antitrust, tort, monopolization, antitrust injury

19.

Citizen Petitions: Long, Late-Filed, and At-Last Denied

66 American University Law Review 305 (2016)
Number of pages: 48 Posted: 30 Aug 2016 Last Revised: 02 Jan 2017
Michael A. Carrier and Carl Minniti
Rutgers Law School and Independent
Downloads 414 (63,594)

Abstract:

Loading...

citizen petition, pharmaceuticals, drugs, 505(q), brands, generics, Copaxone, Mirena, Doryx, EpiPen

20.

Payment after Actavis

100 Iowa Law Review 7 (2014)
Number of pages: 43 Posted: 02 Apr 2014 Last Revised: 30 Dec 2014
Michael A. Carrier
Rutgers Law School
Downloads 400 (66,131)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlement, reverse payments, exclusion payments, poison pill, acceleration clauses, authorized generics

21.

Biologics: The New Antitrust Frontier

2018 U. Ill. L. Rev. 1 (2018)
Number of pages: 70 Posted: 08 Jun 2017 Last Revised: 31 Jan 2018
Michael A. Carrier and Carl Minniti
Rutgers Law School and Independent
Downloads 392 (69,331)

Abstract:

Loading...

biologics, BPCIA, antitrust, settlements, product hopping, REMS, citizen petitions, disparagement, collusion

22.

The Rule of Reason: An Empirical Update for the 21st Century

George Mason Law Review, Vol. 16, No. 827, 2009
Number of pages: 11 Posted: 29 Sep 2009 Last Revised: 04 Oct 2009
Michael A. Carrier
Rutgers Law School
Downloads 392 (67,677)
Citation 2

Abstract:

Loading...

antitrust, rule of reason, balancing, anticompetitive effects, procompetitive justifications

23.

Citizen Petitions: An Empirical Study

Cardozo Law Review, Forthcoming
Number of pages: 46 Posted: 04 Jun 2012 Last Revised: 30 Jul 2013
Michael A. Carrier and Daryl Wander
Rutgers Law School and affiliation not provided to SSRN
Downloads 391 (67,878)

Abstract:

Loading...

citizen petitions, pharmaceutical, patent, antitrust, FDA, generics

24.

How Not to Apply the Rule of Reason: The O’Bannon Case

114 Michigan Law Review First Impressions 73 (2015)
Number of pages: 8 Posted: 11 Oct 2015 Last Revised: 02 Dec 2015
Michael A. Carrier
Rutgers Law School
Downloads 385 (69,122)

Abstract:

Loading...

NCAA, O'Bannon, college sports, amateurism, antitrust, Rule of Reason, less restrictive alternatives, balancing

25.

Unraveling the Patent-Antitrust Paradox

University of Pennsylvania Law Review, Vol. 150, January 2002
Number of pages: 94 Posted: 30 Apr 2002
Michael A. Carrier
Rutgers Law School
Downloads 370 (72,445)
Citation 7

Abstract:

Loading...

Innovation, patent, antitrust, industry, monopoly

26.

Google and Antitrust: Five Approaches to an Evolving Issue

Harvard Journal of Law & Technology Occasional Paper Series - July 2013
Number of pages: 14 Posted: 02 Aug 2013
Michael A. Carrier
Rutgers Law School
Downloads 350 (77,320)

Abstract:

Loading...

Google, antitrust, search neutrality, Google Book search, FTC

27.

Why Antitrust Should Defer to the Intellectual Property Rules of Standard-Setting Organizations: A Commentary on Teece & Sherry

Minnesota Law Review, Vol. 87, p. 2019, 2003
Number of pages: 20 Posted: 05 Aug 2005
Michael A. Carrier
Rutgers Law School
Downloads 339 (80,479)
Citation 1

Abstract:

Loading...

antitrust, intellectual property, standards, standard-setting organizations

28.

Refusals to License Intellectual Property after Trinko

DePaul Law Review, Vol. 55, p. 1191, 2006
Number of pages: 20 Posted: 07 Dec 2006
Michael A. Carrier
Rutgers Law School
Downloads 329 (82,972)
Citation 2

Abstract:

Loading...

Trinko, refusals to license, monopolization, intellectual property, telecommunications

29.

SOPA, PIPA, ACTA, TPP: An Alphabet Soup of Innovation-Stifling Copyright Legislation and Agreements

Northwestern Journal of Technology and Intellectual Property, Vol. 11, No. 2, 2013
Number of pages: 14 Posted: 07 Feb 2013
Michael A. Carrier
Rutgers Law School
Downloads 281 (98,767)

Abstract:

Loading...

copyright, innovation, secondary liability, Stop Online Piracy Act (SOPA), PROTECT IP Act (PIPA), Anti-Counterfeiting Trade Agreement (ACTA), Trans-Pacific Partnership Agreement (TPP)

30.

Why the 'Scope of the Patent' Test Cannot Solve the Drug Patent Settlement Problem

Stanford Technology Law Review, Vol. 16, No. 1, 2012
Number of pages: 8 Posted: 15 Sep 2012
Michael A. Carrier
Rutgers Law School
Downloads 278 (100,336)

Abstract:

Loading...

patents, antitrust, pharmaceuticals, settlements, patent scope

31.

Brief Amici Curiae of 118 Law, Economics, and Business Professors and the American Antitrust Institute in Support of Petitioners

Supreme Court amicus brief in FTC v. Watson, 2013
Number of pages: 62 Posted: 30 Jan 2013
Michael A. Carrier and Mark A. Lemley
Rutgers Law School and Stanford Law School
Downloads 251 (111,186)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlement, Hatch Waxman, reverse payments, exclusion payments, Androgel

32.

Pharmaceutical Antitrust: What the Trump Administration Can Do

Concurrences: Competition Law Review 63 (No. 4, 2016)
Number of pages: 3 Posted: 05 Dec 2016
Michael A. Carrier
Rutgers Law School
Downloads 250 (112,104)

Abstract:

Loading...

pharmaceuticals, drugs, antitrust, patents, FDA, settlements, product hopping, REMS

33.

Solving the Drug Settlement Problem: The Legislative Approach

Rutgers Law Journal, Vol. 41, pp. 81, 2009, Lawyers, Drugs & Money Symposium, Lawyers, Drugs & Money: A Prescription for Antitrust Enforcement in the Pharmaceutical Industry
Number of pages: 21 Posted: 23 Dec 2009 Last Revised: 28 Dec 2013
Michael A. Carrier
Rutgers Law School
Downloads 236 (118,405)

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, Hatch Waxman, reverse payments

34.

Sharing, Samples, and Generics: An Antitrust Framework

103 Cornell Law Review 1 (2017)
Number of pages: 64 Posted: 04 Jun 2017 Last Revised: 22 Nov 2017
Michael A. Carrier
Rutgers Law School
Downloads 234 (119,425)

Abstract:

Loading...

antitrust, patent, pharmaceuticals, drugs, samples, REMS

35.

Pharmaceutical Antitrust Complexity

CPI Antitrust Chronicle (Nov. 2014)
Number of pages: 12 Posted: 25 Nov 2014
Michael A. Carrier
Rutgers Law School
Downloads 226 (124,213)

Abstract:

Loading...

pharmaceuticals, drugs, antitrust, complexity, settlements, product hopping, generics

36.

Pleading Standards: The Hidden Threat to Actavis

91 New York University Law Review Online 31 (2016)
Number of pages: 12 Posted: 21 May 2016 Last Revised: 22 May 2016
Michael A. Carrier
Rutgers Law School
Downloads 223 (125,314)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlement, reverse payments, pleading, Twombly, Iqbal, Actavis, Effexor, Lipitor

37.

Of Trinko, Tea Leaves, and Intellectual Property

Journal of Corporation Law, Vol. 31, 2005
Number of pages: 17 Posted: 28 Feb 2006
Michael A. Carrier
Rutgers Law School
Downloads 221 (126,420)
Citation 1

Abstract:

Loading...

Trinko, refusals to license, monopolization, intellectual property, telecommunications

38.

The D.C. Circuit’s Excessively High Causation Standard in Rambus

Number of pages: 25 Posted: 08 Apr 2010 Last Revised: 25 May 2014
Michael A. Carrier
Rutgers Law School
Downloads 219 (128,091)

Abstract:

Loading...

Antitrust, Standard-Setting, Causation, Rambus, Monopolization, Discon

39.

U.S. Court Upholds Antitrust Action Against Patent Troll

e-Competitions Bulletin, No. 73428, May 2015
Number of pages: 5 Posted: 13 Jun 2015
Michael A. Carrier
Rutgers Law School
Downloads 210 (132,680)

Abstract:

Loading...

patent assertion entity (PAE), nonpracticing entity (NPE), patent troll, antitrust, Intellectual Ventures, Capital One

40.

The Real Rule of Reason: Bridging the Disconnect

Brigham Young University Law Review, Vol. 1999, p. 1265
Number of pages: 102 Posted: 07 Dec 2006
Michael A. Carrier
Rutgers Law School
Downloads 205 (135,752)
Citation 4

Abstract:

Loading...

Rule of Reason, balancing, anticompetitive effects, procompetitive justifications

41.

Post-Grant Opposition: A Proposal and a Comparison to the America Invents Act

UC Davis Law Review, Vol. 45 (2011)
Number of pages: 33 Posted: 14 Mar 2011 Last Revised: 11 Mar 2013
Michael A. Carrier
Rutgers Law School
Downloads 196 (141,515)

Abstract:

Loading...

patents, patent reform, post-grant opposition, America Invents Act

42.

An Antitrust Framework for Climate Change

Northwestern Journal of Technology and Intellectual Property, Vol. 9, No. 8, p. 513, 2011
Number of pages: 22 Posted: 10 Sep 2011
Michael A. Carrier
Rutgers Law School
Downloads 191 (145,043)

Abstract:

Loading...

antitrust, climate change, markets, standards, patent pools, Smart Grid, Eco-Patent Commons, Green Xchange

43.

Vote Counting, Technology, and Unintended Consequences

St. John's Law Review, Vol. 69, 2005
Number of pages: 43 Posted: 30 Aug 2005
Michael A. Carrier
Rutgers Law School
Downloads 191 (145,043)

Abstract:

Loading...

Electronic voting, vote counting, computerization, technology, HAVA, 2004 election

44.
Downloads 182 (151,610)

Abstract:

Loading...

RAND, FRAND, patents, royalties, standards, licensing, SEP

45.

Eight Reasons Why 'No-Authorized-Generic' Promises Constitute Payment

67 Rutgers University Law Review 697 (2015)
Number of pages: 24 Posted: 05 Dec 2014 Last Revised: 05 Sep 2015
Michael A. Carrier
Rutgers Law School
Downloads 161 (168,894)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlement, reverse payments, exclusion payments, authorized generics, Lamictal, Loestrin

46.

A US Court Issues Second Ruling Determining RAND Rate for Standard Essential Patent (Innovatio)

e-Competitions Bulletin, No 58558, 2013
Number of pages: 6 Posted: 24 Nov 2013
Michael A. Carrier
Rutgers Law School
Downloads 157 (172,566)

Abstract:

Loading...

RAND, FRAND, patents, royalties, standards, licensing, SEP, WiFi

47.

Provigil: A Case Study of Anticompetitive Behavior

Hastings Science & Technology Law Journal, Vol. 3, No. 2, pp. 441-452, Summer 2011
Number of pages: 12 Posted: 15 Oct 2011
Michael A. Carrier
Rutgers Law School
Downloads 157 (172,566)

Abstract:

Loading...

patent, antitrust, settlements, product hopping, drugs, Hatch Waxman, Provigil, Cephalon

48.

Innovation for the 21st Century: A Response to Seven Critics

61 Alabama Law Review, Vol. 61, p. 597, 2010
Number of pages: 31 Posted: 11 Oct 2009 Last Revised: 30 Mar 2013
Michael A. Carrier
Rutgers Law School
Downloads 157 (172,566)

Abstract:

Loading...

innovation, patent, copyright, antitrust, IP-antitrust intersection, P2P, statutory damages, DMCA, post-grant opposition, eBay, biotechnology research tools, material transfer agreements (MTAs), innovation markets, standard-setting organizations (SSOs), Hatch-Waxman Act, pharmaceutical settlements

49.

Five Solutions to the REMS Patent Problem

97 Boston University Law Review 1661 (2017)
Number of pages: 47 Posted: 05 Jul 2017 Last Revised: 05 Oct 2017
Michael A. Carrier and Brenna Sooy
Rutgers Law School and Rutgers, The State University of New Jersey - Rutgers Law School
Downloads 156 (174,403)

Abstract:

Loading...

Patent, Drugs, Pharmaceuticals, REMS, FDA

50.

O’Bannon v. National Collegiate Athletic Association: Why the Ninth Circuit Should Not Block the Floodgates of Change in College Athletics

71 Wash. & Lee L. Rev. Online 299, Cleveland-Marshall Legal Studies Paper No. 2575764
Number of pages: 13 Posted: 10 Mar 2015
Michael A. Carrier and Chris Sagers
Rutgers Law School and Cleveland-Marshall College of Law, Cleveland State University
Downloads 152 (177,343)

Abstract:

Loading...

NCAA, O'Bannon, college sports, right of publicity, antitrust, rule of reason, amateurism, less restrictive alternatives

51.

U.S. Court Finds that an Athletics Association's Rules Restricting Payments to Student-Athletes Violate Antitrust Laws (O’Bannon v. NCAA)

e-Competitions Bulletin, No. 68725, Sept. 2014
Number of pages: 8 Posted: 19 Sep 2014
Michael A. Carrier
Rutgers Law School
Downloads 152 (177,343)

Abstract:

Loading...

sports, antitrust, NCAA, right of publicity

52.

How Not to Apply Actavis

Northwestern University Law Review Online, Vol. 109, 2014
Number of pages: 18 Posted: 16 Nov 2014 Last Revised: 10 Dec 2014
Michael A. Carrier
Rutgers Law School
Downloads 151 (178,364)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlement, Actavis, Lamictal, Loestrin, reverse payments, exclusion payments

53.

Why Modularity Does Not (and Should Not) Explain Intellectual Property

Yale Law Journal Pocket Part, Vol. 117, p. 95, 2007
Number of pages: 6 Posted: 04 Feb 2008
Michael A. Carrier
Rutgers Law School
Downloads 151 (178,364)

Abstract:

Loading...

intellectual property, property, modularity, patents, copyrights

54.

A Response to Chief Justice Roberts: Why Antitrust Must Play a Role in the Analysis of Drug Patent Settlements

15 Minnesota Journal of Law, Science & Technology 31 (2014)
Number of pages: 10 Posted: 22 Sep 2013 Last Revised: 08 Mar 2014
Michael A. Carrier
Rutgers Law School
Downloads 139 (191,923)

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, Hatch Waxman, reverse payments

55.

What Is Trump Antitrust?

Concurrences, No. 4, 2016
Number of pages: 26 Posted: 01 Dec 2016
Microsoft Corporation, Sheppard, Mullin, Richter & Hampton LLP, Axinn Veltrop & Harkrider, LLP, Government of the United States of America - Federal Trade Commission, Orrick, Herrington & Sutcliffe, LLP, American Antitrust Institute (AAI), Dechert LLP, Hogan Lovells, Hogan Lovells, Qualcomm, Inc., Bingham McCutchen, LLP, Paul, Weiss, Rifkind, Wharton & Garrison LLP, Skadden, Arps, Slate, Meagher & Flom LLP, General Electric Company, University of California, Berkeley - Department of Economics, Northeastern University - Department of Economics, Wilson Sonsini Goodrich & Rosati, Wilson Sonsini Goodrich & Rosati, Wilson Sonsini Goodrich & Rosati, Loyola University Chicago School of Law, Willkie Farr & Gallagher LLP, Willkie Farr & Gallagher LLP, Rutgers Law School, Hausfeld, Hausfeld and Hausfeld
Downloads 138 (191,923)

Abstract:

Loading...

United States, Antitrust Policy, Presidential Election, Mergers, Cartels, Monopolization, International Cooperation, European Union

56.

Why a 'Large and Unjustified' Payment Threshold is Not Consistent with Actavis

91 Washington Law Review 109 (2016)
Number of pages: 10 Posted: 23 Sep 2015 Last Revised: 05 Apr 2016
Michael A. Carrier
Rutgers Law School
Downloads 138 (191,923)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlement, Actavis, large and unjustified payment, reverse payments, exclusion payments, Rule of Reason

57.

The US Supreme Court Issues First Ruling on Antitrust Legality of Reverse-Payment Drug Patent Settlements (Actavis)

e-Competitions Bulletin, No. 53120, July 2013
Number of pages: 6 Posted: 16 Jul 2013
Michael A. Carrier
Rutgers Law School
Downloads 137 (193,069)

Abstract:

Loading...

Pharmaceuticals, settlements, reverse payments, pay for delay, patent, antitrust, Hatch Waxman, brands, generics

58.

Pictures at the New Economy Exhibition: Why the Antitrust Modernization Commission Got it (Mostly) Right

38 Rutgers Law Journal 473 (2007)
Number of pages: 20 Posted: 09 Jul 2007 Last Revised: 05 May 2015
Michael A. Carrier
Rutgers Law School
Downloads 137 (193,069)

Abstract:

Loading...

antitrust, new economy, Antitrust Modernization Commission (AMC), intellectual property, patents, innovation

59.

Five Arguments Laid to Rest after Actavis

Antitrust Source, Vol. 13 No. 1 (October 2013)
Number of pages: 11 Posted: 06 Nov 2013
Michael A. Carrier
Rutgers Law School
Downloads 133 (197,692)

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, Hatch Waxman, reverse payments, patent scope

60.

A US Court Issues Formalistic Ruling on Reverse-Payment Settlements After 'Actavis' (GlaxoSmithKline/Teva Pharmaceuticals/Louisiana Wholesale Drug Company/King Drug Company)

e-Competitions Bulletin, No. 63588, February 2014
Number of pages: 5 Posted: 17 Feb 2014
Michael A. Carrier
Rutgers Law School
Downloads 125 (207,564)

Abstract:

Loading...

Pharmaceuticals, settlements, reverse payments, patent, antitrust, Actavis, Hatch Waxman, brands, generics, authorized generics

61.

Brief Amici Curiae of 53 Law, Economics, and Business Professors, the American Antitrust Institute, and Consumers Union in Support of Appellants

Third Circuit brief in In re: Lamictal Direct Purchaser Antitrust Litigation, 2014
Number of pages: 41 Posted: 29 Apr 2014
Michael A. Carrier and Steve Shadowen
Rutgers Law School and Hilliard & Shadowen LLP
Downloads 123 (210,106)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, authorized generics, settlements, reverse payments, exclusion payments, Hatch Waxman Act, Lamictal

62.

When is the Senate in Recess for Purposes of the Recess Appointments Clause?

Michigan Law Review, Vol. 92, No. 7, 1994
Number of pages: 44 Posted: 12 Jul 2007
Michael A. Carrier
Rutgers Law School
Downloads 115 (220,888)
Citation 2

Abstract:

Loading...

Recess Appointments Clause, recess, intersession, intrasession

63.

Only 'Scraping' the Surface: The Copyright Hole in the FTC's Google Settlement

46 UBC Law Review (2013)
Number of pages: 19 Posted: 07 Feb 2014
Michael A. Carrier
Rutgers Law School
Downloads 105 (235,737)

Abstract:

Loading...

copyright, antitrust, Google, scraping, fair use, misappropriation, Yelp, reviews

64.

Brief of Amici Curiae 49 Professors in Support of Petitioners

California Supreme Court brief in In re Cipro Cases I & II, 2014
Number of pages: 47 Posted: 19 Mar 2014
Michael A. Carrier and Judith Zahid
Rutgers Law School and Zelle Hofmann Voelbel & Mason LLP
Downloads 96 (250,633)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlements, reverse payments, exclusion payments, Cipro, Hatch Waxman Act, Cartwright Act

65.

The Curious Case of Wellbutrin: How the Third Circuit Mistook Itself for the Supreme Court

103 Cornell L. Rev. Online 137 (2018)
Number of pages: 12 Posted: 29 Aug 2017 Last Revised: 17 Apr 2018
Michael A. Carrier
Rutgers Law School
Downloads 95 (254,054)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, drugs, settlements, reverse payments, risk aversion, Wellbutrin

66.

Brief of Thirty-Four Law Professors as Amici Curiae in Support of Appellants in Altera Corp. v. Papst Licensing GMBH

Southwestern Law School Research Paper No. 2015-25
Number of pages: 28 Posted: 22 Dec 2015 Last Revised: 02 Mar 2017
Southwestern Law School, University at Buffalo Law School, Tulane University Law School, Creighton University School of Law, Benjamin N. Cardozo School of Law, Rutgers Law School, University of Denver Sturm College of Law, Santa Clara University - School of Law, University of Utah - S.J. Quinney College of Law, University of California Hastings College of the Law, University of Kentucky - College of Law, Elon University School of Law, University of California, Davis, University of New Hampshire School of Law, Suffolk University Law School, Boston University School of Law, Emory University, University of Baltimore - School of Law, University of Houston Law Center, Catholic University of America (CUA) - Columbus School of Law, Stanford Law School, University of California Hastings College of the Law, University of Georgia School of Law, St. Thomas University School of Law, St. Thomas University School of Law, Indiana University Robert H. McKinney School of Law, Center for Intellectual Property & Innovation, Michigan State University College of Law, South Texas College of Law, Case Western Reserve University School of Law, Washington and Lee University School of Law, University of St. Thomas School of Law (Minnesota), Florida International University (FIU) - College of Law, Simpson Thacher & Bartlett LLP and University of Pennsylvania Law School - Student/Alumni/Adjunct
Downloads 93 (255,791)

Abstract:

Loading...

patent, declaratory judgment, jurisdiction, personal jurisdiction, patent assertion entity, minimum contacts

67.

The US Federal Trade Commission Issues Report on Patent Assertion Entities

e-Competitions Bulletin, No. 82367, December 2016
Number of pages: 7 Posted: 12 Jan 2017
Michael A. Carrier
Rutgers Law School
Downloads 92 (257,585)

Abstract:

Loading...

PAE, Patent Assertion Entity, Troll, FTC, Antitrust, Patent

Brief Amici Curiae of 48 Law, Economics, and Business Professors and the American Antitrust Institute in Support of Appellants

Third Circuit brief in In re: Effexor XR Antitrust Litigation, 2015
Number of pages: 43 Posted: 18 Nov 2015
Michael A. Carrier and Steve Shadowen
Rutgers Law School and Hilliard & Shadowen LLP
Downloads 51 (360,666)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, authorized generics, settlements, reverse payments, exclusion payments, Hatch Waxman Act, Effexor

Brief Amici Curiae of 48 Law, Economics, and Business Professors and the American Antitrust Institute in Support of Appellants

Third Circuit Brief In re: Lipitor XR Antitrust Litigation, 2015
Number of pages: 43 Posted: 29 Dec 2015
Michael A. Carrier and Steve Shadowen
Rutgers Law School and Hilliard & Shadowen LLP
Downloads 37 (411,401)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlements, reverse payments, exclusion payments, damages forgiveness, Hatch Waxman Act, Lipitor

69.

A U.S. Court Sends Second Reverse-Payment Case to Trial (Cephalon)

e-Competitions Bulletin, No. 71871, January 2015
Number of pages: 5 Posted: 24 Mar 2015
Michael A. Carrier
Rutgers Law School
Downloads 87 (266,849)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, "large and unjustified," settlement, reverse payments, exclusion payments, Cephalon

70.

Reverse-Payment Settlement Agreements Roundtable

ABA Antitrust Health Care Chronicle, 2013
Number of pages: 21 Posted: 13 Apr 2013 Last Revised: 05 May 2015
Michael A. Carrier, Howard Morse, Eric Stock, Kent Bernard and Karen Bokat
Rutgers Law School, Cooley Godward Kronish LLP, Hogan Lovells, Fordham University School of Law and Wiley Rein & Fielding LLP
Downloads 86 (268,719)

Abstract:

Loading...

drug patents, reverse payments, settlements, patent, antitrust, pharmaceuticals, Hatch Waxman Act

71.

2025: Reverse-Payment Settlements Unleashed

Competition Policy International Antitrust Journal, Vol. 2, December 2010
Number of pages: 5 Posted: 16 Jan 2011
Michael A. Carrier
Rutgers Law School
Downloads 86 (268,719)

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, reverse payments, Hatch Waxman

72.

Limiting Copyright Through Property

Forthcoming in Concepts of Property in Intellectual Property (Cambridge 2013)
Number of pages: 17 Posted: 25 Feb 2013
Michael A. Carrier
Rutgers Law School
Downloads 85 (270,679)

Abstract:

Loading...

copyright, property, propertization, rights

73.

What Does State Law Say About Drug Patent Settlements? The California Supreme Court's Cipro Case

Antitrust Health Care Chronicle (April 2015)
Number of pages: 12 Posted: 21 Apr 2015
Michael A. Carrier
Rutgers Law School
Downloads 83 (274,621)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlements, reverse payments, exclusion payments, Cipro, Hatch Waxman Act, Cartwright Act

74.

Five Actions to Stop Citizen Petition Abuse

118 Columbia Law Review Online 81 (2018)
Number of pages: 12 Posted: 28 Sep 2017 Last Revised: 09 Mar 2018
Michael A. Carrier
Rutgers Law School
Downloads 76 (293,871)

Abstract:

Loading...

citizen petitions, pharmaceuticals, drugs, FDA

75.

High Prices & No Excuses: 6 Anticompetitive Games (Presentation Slides)

Testimony for FTC Workshop on “Understanding Competition in Prescription Drug Markets”, 2017
Number of pages: 10 Posted: 08 Nov 2017
Michael A. Carrier
Rutgers Law School
Downloads 74 (293,871)

Abstract:

Loading...

Drugs, Pharmaceuticals, Patent, Antitrust

76.

2008 and 2015: Night and Day for Drug Patent Settlements

CPI Antitrust Chronicle, Dec. 2015
Number of pages: 8 Posted: 16 Dec 2015
Michael A. Carrier
Rutgers Law School
Downloads 73 (296,154)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, settlement, scope-of-patent, Actavis, Lamictal, Cipro, Cephalon, FTC, reverse payments, exclusion payments

77.

Brief Amici Curiae of 58 Law, Economics, and Business Professors in Support of Appellants' Petition for Panel Rehearing or Rehearing En Banc

Third Circuit brief in In re Wellbutrin XL Antitrust Litigation, 2017
Number of pages: 23 Posted: 07 Sep 2017
Michael A. Carrier
Rutgers Law School
Downloads 70 (303,135)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlements, reverse payments, risk aversion, Actavis, Wellbutrin

78.

Front Matter and Introduction to: Intellectual Property and Competition

Edward Elgar Publishing, 2011
Number of pages: 20 Posted: 18 May 2015
Michael A. Carrier
Rutgers Law School
Downloads 69 (305,570)

Abstract:

Loading...

antitrust, competition, intellectual property

79.

Increasing Innovation Through Copyright Common Sense and Better Government Policy

Emory Law Journal, Vol. 62, No. 983, 2013
Number of pages: 15 Posted: 03 Jul 2013
Michael A. Carrier
Rutgers Law School
Downloads 67 (310,461)

Abstract:

Loading...

innovation, copyright, immigration, tax, STEM, statutory damages, personal liability, R&D tax credit, basic research

80.

The Rule of Reason in the Post-Actavis World

2018 Columbia Business Law Review 26
Number of pages: 20 Posted: 23 May 2018
Michael A. Carrier
Rutgers Law School
Downloads 66 (315,408)

Abstract:

Loading...

settlements, pharmaceuticals, drugs, Actavis, Taft, Rule of Reason, O'Bannon, Addyston Pipe, Wellbutrin

81.

Actavis and 'Large and Unjustified' Payments

SCOTUSblog, 2013
Number of pages: 5 Posted: 30 Jul 2013
Michael A. Carrier
Rutgers Law School
Downloads 66 (312,895)

Abstract:

Loading...

patent, antitrust, settlement, drugs, pharmaceuticals, Hatch Waxman, reverse payments, pay for delay

82.

Limelight v. Akamai: Limiting Induced Infringement

Wisconsin Law Review online, 2014:1
Number of pages: 8 Posted: 22 Jul 2014
Michael A. Carrier
Rutgers Law School
Downloads 64 (318,012)

Abstract:

Loading...

patent, inducement, infringement, Akamai, Limelight, Federal Circuit

83.

Copyright and Innovation: Responses to Marks, Masnick, and Picker

2013 Wisconsin Law Review Online
Number of pages: 16 Posted: 12 Jun 2013
Michael A. Carrier
Rutgers Law School
Downloads 62 (325,881)

Abstract:

Loading...

copyright, innovation, creativity, music, record labels, napster, peer-to-peer (p2p)

84.

Foreword: After Actavis: Seven Ways Forward

67 Rutgers University Law Review 543 (2015)
Number of pages: 13 Posted: 09 Sep 2015
Michael A. Carrier
Rutgers Law School
Downloads 61 (325,881)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, Actavis, drug patent settlements, reverse payments, Actavis inference, jury instructions, authorized generics, Cipro, Noerr-Pennington

85.

Brief Amici Curiae on Behalf of 70 Law, Economics, and Business Professors and the American Antitrust Institute in Support of Appellants

First Circuit brief in In re: Loestrin 24 FE Antitrust Litigation, 2015
Number of pages: 45 Posted: 17 Jun 2015
Michael A. Carrier and Kenneth Wexler
Rutgers Law School and Wexler Wallace LLP
Downloads 61 (325,881)

Abstract:

Loading...

patent, antitrust, drugs, pharmaceuticals, authorized generics, settlements, reverse payments, exclusion payments, Hatch Waxman Act, Loestrin

86.

The NCAA's Exploitation of Student-Athletes

Sports Law Blog, 2016
Number of pages: 2 Posted: 24 Mar 2016
Michael A. Carrier
Rutgers Law School
Downloads 59 (331,279)

Abstract:

Loading...

NCAA, amateurism, student-athlete

87.

The U.S. Court of Appeals for the Third Circuit Concludes that the Actavis Ruling Applies to Non-Cash Payments (Lamictal)

e-Competitions Bulletin, No. 75208, August 2015
Number of pages: 4 Posted: 05 Sep 2015
Michael A. Carrier
Rutgers Law School
Downloads 57 (336,862)

Abstract:

Loading...

Pharmaceuticals, settlements, reverse payments, pay for delay, patent, antitrust, authorized generics, Hatch Waxman, brands, generics

88.

The U.S. Court of Appeals for Third Circuit Offers Misguided Analysis of Product Hopping

e-Competitions Bulletin, No. 81744, October 2016
Number of pages: 6 Posted: 31 Oct 2016
Michael A. Carrier
Rutgers Law School
Downloads 56 (342,677)

Abstract:

Loading...

Product Hopping, Drugs, Pharmaceuticals, Antitrust, Patent, Regulation, Doryx, Mylan, Warner Chilcott

89.

The U.S. Court of Appeals for the First Circuit Concludes that a Reverse Payment Need Not Be in Cash (Loestrin)

e-Competitions Bulletin, No. 78533, March 2016
Number of pages: 5 Posted: 21 Mar 2016
Michael A. Carrier
Rutgers Law School
Downloads 55 (342,677)

Abstract:

Loading...

antitrust, patent, Hatch Waxman, drugs, pharmaceuticals, reverse payments, pay for delay

90.

Antitrust after the Interception: Of a Heroic Returner and Myriad Paths

Stanford Law Review, Vol. 55, October 2002
Number of pages: 15 Posted: 04 Dec 2002
Michael A. Carrier
Rutgers Law School
Downloads 49 (361,013)

Abstract:

Loading...

91.

The California Supreme Court Cements Vigorous Scrutiny of Reverse-Payment Settlements (Cipro)

e-Competitions Bulletin, No. 73830, June 2015
Number of pages: 6 Posted: 09 Jul 2015
Michael A. Carrier
Rutgers Law School
Downloads 46 (370,629)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlements, reverse payments, exclusion payments, Cipro, state antitrust law, Cartwright Act

92.

Four Proposals to Enhance Generic Competition (Presentation Slides)

FDA Testimony (2017)
Number of pages: 9 Posted: 18 Jul 2017
Michael A. Carrier
Rutgers Law School
Downloads 45 (373,956)

Abstract:

Loading...

pharmaceuticals, drugs, generics, patents, REMS, citizen petitions, Hatch Waxman

93.

Why the Supreme Court Should Deny Certiorari in King Drug

CPI Antitrust Chronicle (Sept. 2016)
Number of pages: 8 Posted: 24 Sep 2016
Michael A. Carrier
Rutgers Law School
Downloads 44 (377,263)

Abstract:

Loading...

settlements, patent, antitrust, Actavis, pharmaceuticals, drugs, reverse payments, exclusive license

94.

U.S. Court Issues Concerning Ruling on Drug Patent Settlements (Loestrin)

e-Competitions Bulletin, No. 69705, October 2014
Number of pages: 5 Posted: 05 Dec 2014
Michael A. Carrier
Rutgers Law School
Downloads 44 (377,263)

Abstract:

Loading...

patent, antitrust, pharmaceuticals, settlement, reverse payments, exclusion payments, Loestrin

95.

Brief Amici Curiae of the American Antitrust Institute and Consumers Union

ED Pa Brief in In re: Wellbutrin XL Antitrust Litigation
Number of pages: 34 Posted: 02 Oct 2013
Michael A. Carrier
Rutgers Law School
Downloads 42 (384,332)

Abstract:

Loading...

patent, antitrust, settlement, authorized generics, drugs, pharmaceuticals, Hatch Waxman, reverse payment, exclusive license

96.

Brief for the American Antitrust Institute As Amicus Curiae in Support of Petition for Rehearing and Rehearing En Banc

U.S. Court of Appeals for Third Circuit
Number of pages: 16 Posted: 20 Oct 2016
Michael A. Carrier and Richard Brunell
Rutgers Law School and American Antitrust Institute (AAI)
Downloads 41 (387,886)

Abstract:

Loading...

product hopping, antitrust, patent, drugs, pharmaceuticals, Mylan, Warner Chilcott, Namenda

97.

Eliminate Statutory Damages for Secondary Infringers

Department of Commerce Internet Policy Task Force Comment, 2014, Innovation for the 21st Century paperback, Oxford University Press, USA, 2011
Number of pages: 19 Posted: 17 Jan 2014 Last Revised: 19 Jan 2014
Michael A. Carrier
Rutgers Law School
Downloads 38 (398,771)

Abstract:

Loading...

copyright, statutory damages, innovation, secondary liability

98.

The Business of Amateurs: Suffering Student-Athletes and a Thriving NCAA

Number of pages: 2 Posted: 13 Sep 2016
Michael A. Carrier
Rutgers Law School
Downloads 37 (402,627)

Abstract:

Loading...

sports, college, NCAA, football, basketball, amateurism

99.

The 'Equity of the Statute' and Copyright Law: Three Critiques

163 University of Pennsylvania Law Review Online 377 (2015)
Number of pages: 16 Posted: 04 Dec 2015 Last Revised: 09 Dec 2015
Michael A. Carrier
Rutgers Law School
Downloads 32 (422,630)

Abstract:

Loading...

copyright, equity, incentives, access, Kirtsaeng, Feist, Harper & Row, Reed Elsevier, Fogerty, Petrella, Sony, Grokster, Aereo

100.

The U.S. Court of Appeals for the Third Circuit Applies an Appropriate Post-Actavis Pleading Standard (Lipitor)

e-Competitions Bulletin, No. 84937, October 2017
Number of pages: 9 Posted: 20 Nov 2017
Michael A. Carrier
Rutgers Law School
Downloads 31 (426,823)

Abstract:

Loading...

Drugs, Patents, Settlements, Pleading, Actavis, Lipitor, Effexor

101.

The U.S. District Court for the Northern District of California Sets Student-Athletes' Antitrust Case for Trial (NCAA)

e-Competitions Bulletin, No. 87066, May 2018
Number of pages: 5 Posted: 12 Jun 2018
Michael A. Carrier
Rutgers Law School
Downloads 29 (460,592)

Abstract:

Loading...

Sports, antitrust, NCAA, amateurism, Jenkins, O'Bannon, Rule of Reason

102.

Comments on Proposed Update on Intellectual Property Licensing Guidelines

Number of pages: 1 Posted: 03 Sep 2016
Michael A. Carrier
Rutgers Law School
Downloads 29 (435,776)

Abstract:

Loading...

intellectual property, agencies, regulation, industry, patents

103.

Statement by Michael A. Carrier to House Judiciary Committee on 'Antitrust Concerns and the FDA Approval Process'

House Judiciary Committee hearing, July 24, 2017
Number of pages: 3 Posted: 26 Jul 2017
Michael A. Carrier
Rutgers Law School
Downloads 28 (440,417)

Abstract:

Loading...

antitrust, patent, drugs, pharmaceuticals, REMS, CREATES Act, settlements, citizen petitions

104.

Essential Changes to Shared REMS

Comment to Proposed FDA Regulations, 2018
Number of pages: 1 Posted: 01 Aug 2018
Michael A. Carrier
Rutgers Law School
Downloads 7 (574,179)

Abstract:

Loading...

REMS, Drugs, Pharmaceuticals, Brands, Generics, FDA

105.

IP and Competition: Context, Test, and Balance

Comment for FTC Hearings on Competition and Consumer Protection in the 21st Century
Number of pages: 1
Michael A. Carrier
Rutgers Law School
Downloads 0

Abstract:

Loading...

IP, competition, FTC, pharmaceuticals, consumer welfare, patent holdup